Watch the webinar and take the e-learning: ACS Forum 2020 on demand
Watch the webinar and take the e-learning: ACS Forum 2020 on demand
Prof. Gilles Montalescot, Prof. Dr. Kurt Huber, Dr. Sergio Raposeiras Roubín, Prof. Dr. J. Wouter Jukema, Dr. Miklos Rohla, Prof. Dr. Jean-Philippe Collet, Prof. Dr. Ángel Cequier Fillat, Prof. Dr. Jeanine Roeters van Lennep, Prof. Dr. Uwe Zeymer, Prof. Dr. Giovanni Esposito
In December 2020, members of CORONARY CONNECT were pleased to participate in the virtual ACS Forum, an EBAC-accredited webinar. The presentations by ten international experts in the management of acute coronary syndrome are available here for on-demand viewing.
Prof. Gilles Montalescot
Head of Cardiology
Pitié-Salpêtrière Hospital, Paris
France
Prof. Dr. Kurt Huber
Cardiologist
Klinik Ottakring
Austria
Dr. Sergio Raposeiras Roubín
Cardiologist
Alvaro Cunqueiro Hospital
Spain
Prof. Dr. J. Wouter Jukema
Cardiologist
Leiden University Medical Center
Netherlands
Dr. Miklos Rohla
Cardiologist
Klinik Ottakring
Austria
Prof. Dr. Jean-Philippe Collet
Cardiologist
Sorbonne University
France
Prof. Dr. Ángel Cequier Fillat
Cardiologist
University of Barcelona
Spain
Prof. Dr. Jeanine Roeters van Lennep
Internist, Vascular Medicine
Erasmus Medical Center
Netherlands
Prof. Dr. Uwe Zeymer
Cardiologist
Heart Center Ludwigshafen
Germany
Prof. Dr. Giovanni Esposito
Cardiologist
Federico II University of Naples
Italy
Prof. Gilles Montalescot
Head of Cardiology
Pitié-Salpêtrière Hospital, Paris
France
Gilles Montalescot is Professor of Cardiology at the Pitié Salpêtrière Hospital in Paris, France, where he heads the Department of Cardiology at the Institute of Cardiology. He is a practicing Interventional Cardiologist and has extensive experience in basic and clinical research. He has been the director of the INSERM research Unit UMRS_1166 on Thrombosis for 10 years. Dr Montalescot has been an investigator for many of the new drugs developed in the past twenty years as well as for many of the new interventional technologies. Dr. Montalescot is a senior scientist and has been the lead investigator of many national or international randomized trials including ADMIRAL, ARMADA, ALBION, STEEPLE, ARCHIPELAGO, ABOARD, ACAPULCO, ATOLL, ARCTIC, ANTARCTIC, ACCOAST, ATLANTIC, AEGEAN, AMERICA, ALBATROS, and the ongoing ATLANTIS, ALPHEUS, ARAMIS, ADRIFT trials. Dr Montalescot is the Chairman of the ACTION study group, an Academic Research Organization based at Pitié Salpêtrière Hospital in Paris. He has served on several task force committees on antithrombotic drugs and acute coronary syndromes and is the current Chairman of the Stable Coronary Artery disease guidelines of the European Society of Cardiology. Dr Montalescot has received several awards in his country including the J. Valade Prize from the Fondation de France and the J.Escalle award from the National Academy of Medicine. He is a member of several editorial boards and has published over 600 peer reviewed original articles in journals such as the NEJM, JAMA, Lancet. Internationally, Dr. Montalescot has also been an invited speaker at plenary sessions of major congresses such as the European Society of Cardiology, the American College of Cardiology ,and the American Heart Association.
Prof. Dr. Kurt Huber
Cardiologist
Klinik Ottakring
Austria
Dr. Sergio Raposeiras Roubín
Cardiologist
Alvaro Cunqueiro Hospital
Spain
Sergio Raposeiras Roubín (Santiago de Compostela, 26 November 1983) holds a degree in Medicine from the University of Santiago de Compostela (National Award 2007) and a PhD from the same university. He completed his clinical fellowship in cardiology at the Clinical Hospital in Santiago de Compostela, with a short training in the Royal Bromptom Hospital of London and in the Montefiori Hospital of New York (National Award to the Best Fellowship 2013). He has two master's degrees (in Clinical Cardiology from the Miguel Hernández University, and in Statistics in Health Sciences for the Universidad Complutense de Madrid), and two postgraduate degrees (in Research Methodology from the Univesidad Autonoma de Barcelona, and in Cardiovascular Imaging from the Spanish Society of Cardiology). From May 2013 to January 2016 he developed his clinical care activity as Clinical Cardiologist at the Clinical Hospital of Santiago de Compostela, and since February 2016 he is staff of the Cardiology Department of the Alvaro Cunqueiro Hospital from Vigo, where he is Coordinator of Clinical Research. Collaborator at the University of Santiago de Compostela, he is a Professor of Master programs (Heart Failure and Diabetes, coordinated by the Spanish Society of Cardiology) and a usual speaker of courses from Spanish Society of Cardiology. He is also Associate Editor of BMC Cardiovascular Disorders and REC:Cardioclinics, and reviewer of more than 10 scientific journals including the Journal of American Collegue of Cardiology and the European Heart Journal. He has been invited as a speaker in Congresses from Italian Society of Cardiology and American College of Cardiology. He is member of the scientific committee of the CardioGroup (international project to promote cardiovascular clinical research in young cardiologists) and he is also part of the International Leadership Group of American Collegue of Cardiology. During his clinical training he initiated a translational research project on the involvement of advanced glycation products in heart failure, obtaining the Pfyzer Prize for discovering the role of advanced glycation in atrial fibrillation. His current clinical research projects focus on risk stratification and post-infarction therapies. In 2012 he won an American Collegue of Cardiology Award for the best article published in JACC Cardiovascular Intervention for a researcher under 40 years old. He have defended more than 200 communications in national and international congresses, with more than 140 indexed publications (38% as first author) with an average impact factor higher than 4 (index H 21, with average citation in the last year of 1 cite per day), being the author of 1 book and chapters in 23 books. He is coordinator of 2 international projects in acute coronary syndrome: the BleeMACS registry (multicenter international project for the study of bleeding in acute coronary syndrome) and the RENAMI registry (European project for the study of new antiplatelet agents ). From the BleeMACS Project, he developed a score to predict the risk of post-infarction bleeding (BleeMACS score), from which he derived an online calculator and a mobile app that allow identifying patients who benefit from a more intensive antithrombotic therapy, being cited by European and international recommendations for the management of post-infarction patients with high risk of bleeding. Since 2017, he was involved in the direction of a clinical trial (REBOOT trial) about the utility of beta-blockers in after myocardial infarction
Dr. Sergio Raposeiras Roubín has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Amgen, Bayer, Boehringer, Daichii and Bayer.
Prof. Dr. J. Wouter Jukema
Cardiologist
Leiden University Medical Center
Netherlands
Dr. Miklos Rohla
Cardiologist
Klinik Ottakring
Austria
Dr. Rohla is currently completing his specialist training in cardiology at the 3rd Medical Department for Cardiology and Intensive Care Medicine, Klinik Ottakring (formerly Wilhelminenhospital) in Vienna, Austria. His research is focused around the medical and invasive treatment of acute coronary syndromes, antithrombotic therapies in patients with coronary artery disease or atrial fibrillation, and control of risk factors such as hypertension or hyperlipidaemia. Main clinical areas of interest are interventional cardiology and intensive care medicine.
Dr. Miklos Rohla has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Sanofi Aventis.
Prof. Dr. Jean-Philippe Collet
Cardiologist
Sorbonne University
France
Prof. Dr. Ángel Cequier Fillat
Cardiologist
University of Barcelona
Spain
Prof. Dr. Jeanine Roeters van Lennep
Internist, Vascular Medicine
Erasmus Medical Center
Netherlands
Prof. Dr. Uwe Zeymer
Cardiologist
Heart Center Ludwigshafen
Germany
Prof. Dr. Giovanni Esposito
Cardiologist
Federico II University of Naples
Italy
E-learning |
60 min
|accreditation:
EACCME |
Sep 2021
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
Watch presentations on these key topics in ACS:
-
The year when COVID-19 hit the heart
-
Drugs in ACS: Acute phase & post-discharge
-
An unusual ACS: Case study 1
-
Devices in the Cath lab
-
An alternative case of ACS: Case study 2
-
Debate: Early vs. late treatment for NSTEMI
-
Challenging clinical situations: Bleeding risk & Heart failure with ACS
The ACS Forum presentations are relevant for a broad healthcare professional audience including cardiologists and lipidologists, as well as nurses and physicians from the emergency room (ER), critical/intensive care unit (CCU/ICU), and primary care settings.
Maximize your ACS Forum educational journey: visit COR2ED Checkpoint to access the on-demand accredited e-learning associated with this programme.
The ACS Forum is a medical educational programme supported by an Independent Educational Grant from Amgen.
CORONARY CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Amgen.
Other programmes of interest
Other programmes developed by Prof. Gilles Montalescot
Other programmes developed by Prof. Dr. Jeanine Roeters van Lennep
Prof. Dr. Jeanine Roeters van Lennep
Internist, Vascular Medicine
Erasmus Medical Center
Netherlands
Other programmes developed by Prof. Dr. Uwe Zeymer
Prof. Dr. Uwe Zeymer
Cardiologist
Heart Center Ludwigshafen
Germany